Trial Profile
A Phase 2 study of intra-articular injection of DE-098 in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs DE 098 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Santen Pharmaceutical
- 25 May 2016 New trial record